Compounds > substance p
Page last updated: 2024-08-23

substance p and Cardiomyopathies, Primary

substance p has been researched along with Cardiomyopathies, Primary in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (66.67)18.2507
2000's1 (16.67)29.6817
2010's0 (0.00)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Block, M; Gharraee, N; Goslen, KH; Kavanagh, K; Lacy, JL; Levick, SP; Meléndez, GC; Whitfield, J; Widiapradja, A1
Cassidy, MM; Dickens, BF; Kramer, JH; Mak, IT; Phillips, TM; Stafford, R; Weglicki, WB1
Agis, H; Bankl, HC; Glogar, D; Grossschmidt, K; Imhof, M; Klappacher, G; Laufer, P; Lechner, K; Mundigler, G; Radaszkiewicz, T; Simon, P; Sperr, WR; Valent, P1
Correa-de-Araujo, R; Walsh, RJ; Weglicki, WB1
Cooper, A; Heagerty, AM1
Edvinsson, L; Saetrum Opgaard, O; Saxena, PR; Ytterberg, HT1

Other Studies

6 other study(ies) available for substance p and Cardiomyopathies, Primary

ArticleYear
Replacement substance P reduces cardiac fibrosis in monkeys with type 2 diabetes.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2023, Volume: 160

    Topics: Animals; Cardiomyopathies; Chlorocebus aethiops; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Female; Fibrosis; Mice; Myocardium; Stroke Volume; Substance P; Ventricular Function, Left

2023
Cytokines, neuropeptides, and reperfusion injury during magnesium deficiency.
    Annals of the New York Academy of Sciences, 1994, Jun-17, Volume: 723

    Topics: Animals; Calcitonin Gene-Related Peptide; Cardiomyopathies; Cricetinae; Cytokines; Inflammation; Magnesium Deficiency; Myocardial Reperfusion Injury; Neuropeptides; Rats; Reactive Oxygen Species; Substance P; Time Factors; Vitamin E

1994
The human cardiac mast cell: localization, isolation, phenotype, and functional characterization.
    Blood, 1994, Dec-01, Volume: 84, Issue:11

    Topics: Antibodies, Monoclonal; Antigens, Surface; Calcimycin; Cardiomyopathies; Cell Count; Cell Separation; Chymases; Hematopoietic Cell Growth Factors; Histamine Release; Humans; Immunoglobulin E; Immunophenotyping; Mast Cells; Myocardium; N-Formylmethionine Leucyl-Phenylalanine; Organ Specificity; p-Methoxy-N-methylphenethylamine; Serine Endopeptidases; Staining and Labeling; Stem Cell Factor; Substance P; Tryptases

1994
Distribution of specific substance P binding sites in the heart and adjacent great vessels of the Wistar white rat.
    Cell and tissue research, 1996, Volume: 284, Issue:3

    Topics: Animals; Aorta; Arteries; Autoradiography; Binding Sites; Cardiomyopathies; Coronary Vessels; Heart Valves; Magnesium Deficiency; Male; Muscle Fibers, Skeletal; Muscle, Smooth, Vascular; Myocardium; Rats; Rats, Wistar; Silver Staining; Substance P

1996
Endothelial dysfunction in human intramyocardial small arteries in atherosclerosis and hypercholesterolemia.
    The American journal of physiology, 1998, Volume: 275, Issue:4

    Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acetylcholine; Adult; Arteries; Arteriosclerosis; Bradykinin; Cardiomyopathies; Coronary Circulation; Endothelium, Vascular; Female; Heart; Heart Failure; Heart Transplantation; Humans; Hypercholesterolemia; In Vitro Techniques; Isometric Contraction; Male; Middle Aged; Nitroprusside; Substance P; Vasodilation

1998
Influence of ageing on vasomotor responses of human epicardial coronary arteries.
    Pharmacology & toxicology, 2000, Volume: 86, Issue:4

    Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adult; Aged; Aged, 80 and over; Aging; Calcitonin Gene-Related Peptide; Cardiomyopathies; Coronary Vessels; Dose-Response Relationship, Drug; Endothelins; Humans; In Vitro Techniques; Middle Aged; Norepinephrine; Substance P; Vasoactive Intestinal Peptide; Vasoconstriction; Vasoconstrictor Agents; Vasodilation; Vasomotor System

2000